請選擇規(guī)格
¥12748.73
以上報價是含稅價格
規(guī)格
貨號:
規(guī)格
規(guī)格 | 4樣本、8樣本、2樣本、4樣本(產(chǎn)品加服務(wù))、2樣本(產(chǎn)品加服務(wù))、8樣本(產(chǎn)品加服務(wù)) |
樣本類型 | Cell Culture Supernatants, Plasma, Serum, Tissue Lysates, Cell Lysates |
原理方法 | Sandwich-based |
檢測方法 | Chemiluminescence |
定量與否 | Semi-Quantitative |
載體 | Membrane |
適用種屬 | Mouse |
檢測靶標 | CXCL16, MIP-2, LIX, MCP-5, MIP-1 gamma, Eotaxin-1 / CCL11, MIP-1 alpha / CCL3, RANTES / CCL5, BLC / CXCL13, MIG / CXCL9, CXCL2 / CINC-3 / MIP2, MCP-1 / CCL2, CXCL1 / GRO alpha / KC / CINC-1, MIP-3 alpha / CCL20, 6Ckine / CCL21, CTACK / CCL27, ENA-78 / CXCL5, Eotaxin-2 / MPIF-2 / CCL24, Fractalkine / CX3CL1, I-309 / TCA-3 / CCL1, I-TAC / CXCL11, MDC / CCL22, MIP-3 beta / CCL19, Platelet Factor 4 / CXCL4, TARC / CCL17, TECK / CCL25, SDF-1 / CXCL12 |
靶標數(shù) | 25 |
詳細描述
Scroll over each target protein for more information | ||||
---|---|---|---|---|
6Ckine (CCL21)
| BLC (CXCL13)
| CTACK (CCL27)
| CXCL16
| Eotaxin-1 (CCL11)
|
Eotaxin-2 (MPIF-2/CCL24)
| Fractalkine (CX3CL1)
| I-TAC (CXCL11)
| KC (CXCL1)
| LIX
|
MCP-1 (CCL2)
| MCP-5
| MDC (CCL22)
| MIG (CXCL9)
| MIP-1 alpha (CCL3)
|
MIP-1 gamma
| MIP-2
| MIP-3 beta (CCL19)
| MIP-3 alpha (CCL20)
| Platelet Factor 4 (CXCL4)
|
RANTES (CCL5)
| SDF-1 (CXCL12)
| TARC (CCL17)
| I-309 (TCA-3/CCL1)
| TECK (CCL25)
|
相關(guān)產(chǎn)品
Human Immune Checkpoint Receptor Protein Array
CHO Residual DNA Quantification Kit
Uric Acid Assay Kit (Colorimetric)
Total Cholesterol Assay Kit (Colorimetric)
Superoxide Dismutase (SOD) Activity Assay Kit (Colorimetric)
Peroxidase Activity Assay Kit (Colorimetric)
文件
文獻(4)
Abstract 586: Development of a novel pan-chemokine receptor inhibitor as therapeutic for breast cancer,Hongmei Song, Gang Wang, Bin He, Li Li, Caixia Li, Yusi Lai, Xianghui Xu, Zhongwei Gu,International Journal of Nanomedicine ,(IF:7.033) 作者單位:四川大學(xué) | |
Species: | Mouse |
Sample Type: | serum |
Nociception-Dependent CCL21 Induces Dorsal Root Ganglia Axonal Growth via CCR7-ERK Activation,Yang Xiaosheng, Liu Yang, Zhong Weijie, Li Yi, Zhang Wenchuan,Frontiers in Immunology ,(IF:7.3) 作者單位:上海交通大學(xué)醫(yī)學(xué)院附屬第九人民醫(yī)院 | |
Species: | Mouse |
Sample Type: | unknown |
Programming Cell-Derived Vesicles with Enhanced Immunomodulatory Properties,Zhang Rui, Dong Mengxue, Tu Juchuanli, Li Fengkai, Deng Qiaodan, Xu Jiahui, He Xueyan, Ding Jiajun, Xia Jie, Sheng Dandan, Chang Zhaoxia, Ma Wei, Dong Haonan, Zhang Yi, Zhang Lixing, Zhang Lu, Liu Suling,Signal Transduction and Targeted Therapy ,(IF:39.3) 作者單位:復(fù)旦大學(xué)附屬腫癌醫(yī)院 | |
Species: | Mouse |
Sample Type: | unknown |
RAI16 maintains intestinal homeostasis and inhibits NLRP3‐dependent IL‐18/CXCL16‐induced colitis and the progression of colitis‐associated colorectal cancer,Deniz Ceylanl?, Ahmet ?zer ?ehirli, Sevgi Gen?osman, Kerem Teral?, Hüseyin ?ah, Nurhayat Gülmez, Serkan Say?ner,Antioxidants ,(IF:7.675) | |
Species: | Mouse |
Sample Type: | colon |
通過郵件收到學(xué)術(shù)資源和優(yōu)惠信息
微信公眾號